Laurie Belknap
Family · Endicott, NYNPI 1508096181
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $84 and has fallen 78.1% since, to $18 in 2024. That places this record below the midpoint for family clinicians in NY, where the typical reported total is $299.
Across 9 payments — averaging $16.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$20
- Novo Nordisk$19
- GSK$18
- AbbVie$17
- Otsuka America Pharmaceutical, Inc.$17
- Abbott$16
- plus $41 from 3 others
What the payments were for
- Food & beverage$149100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 1 | $20 |
| Novo Nordisk | 1 | $19 |
| GSK | 1 | $18 |
| AbbVie | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Abbott | 1 | $16 |
| Pfizer | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
How this compares
$149 in reported general payments places this provider in the 30th percentile of 8,883 family providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 61 | $2,091 |
| Doxycycline Hyclate | 113 | $671 |
| Triamcinolone Acetonide | 31 | $600 |
| Cephalexin | 60 | $455 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 48 | $451 |
| Cefdinir | 22 | $290 |
| Clotrimazole | 23 | $271 |
| Prednisone | 87 | $175 |
| ValacyclovirValacyclovir Hcl | 12 | $160 |
| Nystatin | 12 | $157 |
| Ciprofloxacin Hcl | 27 | $103 |
| Tobramycin | 17 | $90 |
| Dexamethasone | 13 | $89 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 31 | $71 |
| Amoxicillin | 13 | $43 |
Paid to pharmacies, not to this prescriber.
Other family in Endicott
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
- John de OcaStaten Island$86K
- Fara StrickerGlen Oaks$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.